MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: Domain
Celator Pharmaceuticals, Inc.
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Industry: New Jersey
*Portfolio Companies: Domain
*Portfolio Companies: Quaker BioVentures
Venture Capital: Series E
Children
Celator Pharmaceuticals raising $5 million for cancer treatments (2011)
Celator raised $20 million in its series D financing round.(2010)
Celator’s approach to cancer treatment is based on a synergistic ratio of drugs to improve tumor cell kill and locks the synergistic ratio in a drug-delivery vehicle to maintain the ratio in patients
Development of proprietary fixed dose combinations of chemotherapeutic agents for cancer treatment
Drug therapy for acute myeloid leukemia moves through phase 2 clinical trials.
It counts Quaker BioVentures, Ventures West, Domain Associates and GrowthWorks among its 10 investors.
Princeton, New Jersey
Princeton, New Jersey 08543